The financial press is full of stories about Pfizer this morning, and its planned takeover of Astrazeneca. A recurring theme is the tax dimension of
Read the full article…
Richard Murphy
Support Tax Research
Subscribe by Email
If you enjoyed this blog, please subscribe free by email.